Kay Palmer, Ph.D.

Senior Patent Agent

Kay Palmer drafts and prosecutes patents in the fields of biochemical, bioinformatics, pharmaceutical and molecular biology, with an emphasis on molecular biology, immunology and gene therapy. Kay corresponds with foreign associates in order to coordinate the IP needs of national and international clients. Kay also has expertise in the Patented Medicines (Notice of Compliance) Regulations, particularly on issues relating to patent claim eligibility for listing patents. Kay has assisted clients in the preparation and submission of patent lists as well as assisting in patent litigation matters.

Kay`s experience in the fields of scientific research consists of projects in the development of novel anti-cancer therapies, which include anti-cancer immunotherapy, anti-cancer gene therapy, antisense and anti-angiogenesis approaches. Kay also assisted in the teaching of undergraduate courses in immunology.

Her expertise extends to a variety of scientific techniques including a wide range of molecular biology, gene therapy and immunology techniques. Kay has constructed and tested numerous adenoviral vectors and has experience in the construction of single chain antibodies as well as the use of a variety of immunological assays, such as CTL assays, ELISAs, immunohistochemistry and Western Blotting.

Kay has co-authored several paper related to her research in the development of effective therapies for the treatment of cancer, and her papers have appeared in the American Journal of Pathology, Journal of Immunology and Journal of Gene Therapy. She has also presented her research at various international conferences.

Kay is a Registered Canadian Patent Agent and also has limited recognition to represent Canadians in patent matters before the USPTO. 


  • B.Sc., Biology, McMaster University

  • Ph.D., Molecular Biology, McMaster University

cb photo 124 561ead1bced0d


Patent Agent

Poonam’s focuses on the drafting and prosecution of pharmaceutical, chemical, biochemical, petrochemical, and polymer patent applications around the world.
MBM read_more_btn


MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More